Scinovex
article Open AccessTop 10% cited

Clinical implications of Brief Psychiatric Rating Scale scores

The British Journal of Psychiatry · 2005 · Vol. 187(4) · pp. 366–371
Stefan LeuchtJohn M. KaneWerner KisslingJohannes HamannEva EtschelRolf R. Engel

Abstract

The results provide a clearer understanding of how to interpret BPRS total and percentage reduction scores in clinical trials with patients acutely ill with schizophrenia who are experiencing positive symptoms.

Schizophrenia research and treatmentMental Health and PsychiatryPsychiatric care and mental health servicesBrief Psychiatric Rating ScaleSchizophrenia (object-oriented programming)Rating scaleClinical Global ImpressionDrug trialClinical trialMedicineInternal medicinePsychologyPsychiatry

MeSH terms

OlanzapineAmisulprideAcute DiseaseAdultBenzodiazepinesFemaleHumansMalePsychiatric Status Rating ScalesSchizophreniaSeverity of Illness IndexSulpirideAntipsychotic AgentsTreatment Outcome

Funding

  • Eli Lilly and Company
  • Sanofi
Citations
886
FWCI
9.52
field-weighted impact
References
35
Percentile
99%
vs. same field & year
Citations per year
References
Olanzapine versus Placebo and Haloperidol
Neuropsychopharmacology · 1996 · 785 citations
Clozapine for the Treatment-Resistant Schizophrenic
Archives of General Psychiatry · 1988 · 4,110 citations
A RATING SCALE FOR DEPRESSION
Journal of Neurology Neurosurgery & Psychiatry · 1960 · 32,326 citations
A New Depression Scale Designed to be Sensitive to Change
The British Journal of Psychiatry · 1979 · 13,782 citations
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
American Journal of Psychiatry · 2005 · 2,305 citations
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
Schizophrenia Bulletin · 1987 · 21,169 citations
ECDEU Assessment Manual for Psychopharmacology
Bulletin of Miscellaneous Information (Royal Gardens Kew) · 1976 · 8,823 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.